三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
舒沃替尼联合戈利昔替尼显示出优于单药的临床前疗效
舒沃替尼联合戈利昔替尼显示出优于单药的临床前疗效
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:488KB
图片尺寸:2268*574
同报告图片
/
4
fCDlrp7pqozml7bpl7TvvIjlpKnvvIkgfCDmuLjnprvlr7nnhafnu4TvvIhuPTfvvIkgfCBEWkQ5MDA4IDMgbWcva2cgYmlkIHAubyAobj03KSB8IERaRDkwMDggMTAgbWcva2cgYmlkIHAubyAobj03KSB8IERaRDkwMDggMjAgbWcva2cgYmlkIHAubyAobj03KSB8IERaRDkwMDggNDAgbWcva2cgYmlkIHAubyAobj03KSB8IERaRDkwMDggMyBtZy9rZyBiaWQgKyBEWkQ0MjA1IDEwIG1nL2tnIGJpZCAobj03KSB8IERaRDkwMDggMyBtZy9rZyBiaWQgKyBEWkQ0MjA1IDIwIG1nL2tnIGJpZCAobj03KSB8IERaRDkwMDggMyBtZy9rZyBiaWQgKyBEWkQ0MjA1IDQwIG1nL2tnIGJpZCAobj03KSB8CnwtLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCAwICAgICAgICAgICAgICB8IDQwMMKxNTAgICAgICAgICAgIHwgNDAwwrE1MCAgICAgICAgICAgICAgICAgICAgICAgICB8IDQwMMKxNTAgICAgICAgICAgICAgICAgICAgICAgICAgfCA0MDDCsTUwICAgICAgICAgICAgICAgICAgICAgICAgIHwgNDAwwrE1MCAgICAgICAgICAgICAgICAgICAgICAgICB8IDQwMMKxNTAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDQwMMKxNTAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDQwMMKxNTAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgNyAgICAgICAgICAgICAgfCA2MDDCsTUwICAgICAgICAgICB8IDYwMMKxNTAgICAgICAgICAgICAgICAgICAgICAgICAgfCA2MDDCsTUwICAgICAgICAgICAgICAgICAgICAgICAgIHwgNjAwwrE1MCAgICAgICAgICAgICAgICAgICAgICAgICB8IDYwMMKxNTAgICAgICAgICAgICAgICAgICAgICAgICAgfCA2MDDCsTUwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCA2MDDCsTUwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCA2MDDCsTUwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDE0ICAgICAgICAgICAgIHwgODAwwrE1MCAgICAgICAgICAgfCA4MDDCsTUwICAgICAgICAgICAgICAgICAgICAgICAgIHwgODAwwrE1MCAgICAgICAgICAgICAgICAgICAgICAgICB8IDgwMMKxNTAgICAgICAgICAgICAgICAgICAgICAgICAgfCA4MDDCsTUwICAgICAgICAgICAgICAgICAgICAgICAgIHwgODAwwrE1MCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgODAwwrE1MCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgODAwwrE1MCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMSAgICAgICAgICAgICB8IDEwMDDCsTUwICAgICAgICAgIHwgMTAwMMKxNTAgICAgICAgICAgICAgICAgICAgICAgICB8IDEwMDDCsTUwICAgICAgICAgICAgICAgICAgICAgICAgfCAxMDAwwrE1MCAgICAgICAgICAgICAgICAgICAgICAgIHwgMTAwMMKxNTAgICAgICAgICAgICAgICAgICAgICAgICB8IDEwMDDCsTUwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDEwMDDCsTUwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDEwMDDCsTUwICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CgrotYTmlpnmnaXmupDvvJpUS0nogJDoja/nmoRFR0ZS5pWP5oSf56qB5Y+Y5Z6L5pma5pyfTlNDTEPmsrvnlpfnrZbnlaXmjqLorqjvvIzpppblsYpDU0NP6L+q5ZOy6IK655mM6auY5bOw6K665Z2b
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
5aW955qE77yM5Lul5LiL5piv5oKo5Zu+54mH5Lit55qE5pWw5o2u6KGo5qC85ZKM6LWE5paZ5p2l5rqQ77yaCgp8IOWFrOWPuCB8IOiNr+eJqSB8IOa1t+WkluS4tOW6iumYtuautSB8IOS4reWbveS4tOW6iumYtuautSB8IOWbveWGhemmluasoeWFrOekuuaXtumXtCB8IOWJgumHjyB8IE9SUiB8IOaVsOaNruWfuuS6juS6uuaVsCB8IOWPkeihqOaXtumXtCB8CnwtLS0tLS18LS0tLS0tfC0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS18LS0tLS0tfC0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS18Cnwg5by655SfIHwgQW1pdmFudGFtYWIgfCBJSUnvvIjlt7LkuIrluILvvIkgfCAqIHwgMjAyMC4xMi44IHwgPDgwa2fkuLoxMDUwbWfvvIziiaU4MGtn5Li6MTQwMG1nIHwgNDAlIHwgMzYyIHwgMjAyMFdDTEMgfAp8IOatpueUsCB8IE1vYm9jZXJ0aW5pYiB8IElJSe+8iOW3suS4iuW4gu+8iSB8IOW3suS4iuW4giB8IDIwMTkuNC45IHwgMTYwbWcvcWQgfCAyOCUgfCAxMTQgfCAyMDIxQVNDTyB8Cnwg6L+q5ZOy5Yy76I2vIHwg6IiS5rKD5pu/5bC8IHwgSUkgfCAgfCAyMDIxLjUuMTIgfCAzMDBtZy9xZCB8IDU5LjglIHwgOTcgfCAyMDIyRVNNTyB8CnwgU3BlY3RydW0gUGhhcm1hY2V1dGljYWxzIHwg5rOi5aWH5pu/5bC8IHwgSUkgfCDlt7LkuK3mraIgfCAgfCAxNm1nL3FkIHwgMzIlIHwgNTAgfCAyMDIyIENhbmNlciBDZWxsIOacn+WIiiB8CnwgQ3VsbGluYW5PbmNvbG9neS/lho3pvI7ljLvoja8gfCBDTE4tMDgxIHwgSS9JSWEgfCBJSS9JSWEgfCAyMDIxLjcuMjMgfCAxMDBtZy9iaWQgfCA0MSUgfCAzOSB8IDIwMjJBU0NPIHwKfCDoib7lipvmlq8gfCDkvI/nvo7mm7/lsLwgfCBJSSB8ICB8IDIwMjIuNi44IHwgMjQwbWcvcWQgfCA2MCUgfCAxMCB8IDIwMjFFU01PIHwKfCDlv4XotJ3nibnljLvoja8gfCBCRUJULTEwOSB8IElJIHwgIHwgMjAyMC4xLjEzIHwgMTIw44CBMTgw44CBMjQwbWcvcWQgfCBEQ1I9MTAwJSB8IDE5IHwgMjAyMuaLm+iCoeS5piB8Cnwg5ZCb5a6e55Sf54mpL+W+ruWig+eUn+eJqSB8IEFQTC0xODk4IHwgSUkgfCAgfCAyMDIxLjEyLjMxIHwgIHwgIHwgIHwgIHwKfCDnpo/msoPoja/kuJogfCBGV0QxNTA5IHwgSSB8ICB8IDIwMjEuNy4yMyB8ICB8ICB8ICB8ICB8Cnwg57+w5qOu5Yi26I2vIHwgSFMtMTAzNzYgfCBJIHwgIHwgMjAyMS4xMC4xMSB8ICB8ICB8ICB8ICB8Cnwg5Lit5Zu95Yy76I2v56CU56m25byA5Y+R5Lit5b+D5pyJ6ZmQ5YWs5Y+4IHwgTklQMTQyIHwgSSB8ICB8IDIwMjIuNC4xMyB8ICB8ICB8ICB8ICB8CgrotYTmlpnmnaXmupDvvJppbnNpZ2h05pWw5o2u5bqT77yM5ZCE5YWs5Y+45a6Y572R77yM5b+F6LSd54m55Yy76I2v5oub6IKh6K+05piO5Lmm77yM5Lit5L+h6K+B5Yi456CU56m26YOo77yI5rOo77yaQW1pdmFudGFtYWLlnKjlm73lhoXnmoRJSeacn+S4tOW6iumAguW6lOeXh+aYr+iBlOWQiOesrOS4iQ==
fCDoja/niakgICB8IOe+juWbveS4iuW4guaXtumXtCB8IOS4reWbveS4iuW4guaXtumXtCB8IOS4gOe6v+mAguW6lOeXhyB8IOS6jOe6v+mAguW6lOeXhyB8CnwtLS0tLS18LS0tLS0tLS0tLXwtLS0tLS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tLXwKfCDlkInpnZ7mm7/lsLwgfCAyMDAzLjUuNSB8IDIwMDQuNi4xMiB8IOaQuuW4piBFR0ZSIERlbDE5IOWSjCBMODU4UiDnqoHlj5jnmoTmmZrmnJ8gTlNDTEMgfCDml6LlvoDmjqXlj5fov4foh7PlsJHkuIDmrKHljJbnlpflpLHotKXnmoTlsYDpg6jmmZrmnJ/miJbovaznp7vmgKcgTlNDTEMgfAp8IOWOhOa0m+abv+WwvCB8IDIwMDQuMTEuMTggfCAyMDA2LjMuNCB8IOaQuuW4piBFR0ZSIERlbDE5IOWSjCBMODU4UiDnqoHlj5jnmoTmmZrmnJ8gTlNDTEMgfCDml6LlvoDmjqXlj5fov4foh7PlsJHkuIDmrKHljJbnlpflpLHotKXnmoTlsYDpg6jmmZrmnJ/miJbovaznp7vmgKcgTlNDTEMgfAp8IOWfg+WFi+abv+WwvCB8IDIwMTEuNi43IHwgIHwg5pC65bimIEVHRlIgRGVsMTkg5ZKMIEw4NThSIOeqgeWPmOeahOaZmuacnyBOU0NMQyB8IOaXouW+gOaOpeWPl+i/h+iHs+WwkeS4gOasoeWMlueWl+Wksei0peeahOWxgOmDqOaZmuacn+aIlui9rOenu+aApyBOU0NMQyB8Cnwg6Zi/5rOV5pu/5bC8IHwgMjAxMy43LjEyIHwgMjAxNy4yLjIxIHwg4pGg5pC65bimIEVHRlIgRGVsMTkg5ZKMIEw4NThSIOeqgeWPmOeahOaZmuacnyBOU0NMQyDikaHnvZXop4EgRUdGUiDnqoHlj5ggKEw4NjFRLCBHNzE5WCDlkowv5oiWIFM3NjhJKSDnmoTovaznp7vmgKcgTlNDTEMgfCDml6LlvoDmjqXlj5fov4foh7PlsJHkuIDmrKHljJbnlpflpLHotKXnmoTlsYDpg6jmmZrmnJ/miJbovaznp7vmgKcgTlNDTEMgfAp8IOi+vuWPr+abv+WwvCB8IDIwMTguOS4yNyB8IDIwMTkuNS4xNSB8IOaQuuW4piBFR0ZSIERlbDE5IOWSjCBMODU4UiDnqoHlj5jnmoTmmZrmnJ8gTlNDTEMgfCAgfAp8IOWlpeW4jOabv+WwvCB8IDIwMTUuMTEuMTMgfCAyMDE3LjMuMjIgfCDmkLrluKYgRUdGUiBEZWwxOSDlkowgTDg1OFIg56qB5Y+Y55qE5pma5pyfIE5TQ0xDIHwg5pei5b6AIEVHRlItVEtJIOayu+eWl+WQjuWHuueOsOeWvueXhei/m+Wxle+8jOWtmOWcqCBFR0ZSIFQ3OTBNIOeqgeWPmOmYs+aAp+eahOWxgOmDqOaZmuacn+aIlui9rOenu+aApyBOU0NMQyB8Cnwg6Zi/576O5pu/5bC8IHwgMjAyMC4zLjE3IHwgIHwg5pC65bimIEVHRlIgRGVsMTkg5ZKMIEw4NThSIOeqgeWPmOeahOaZmuacnyBOU0NMQyB8IOaXouW+gCBFR0ZSLVRLSSDmsrvnlpflkI7lh7rnjrDnlr7nl4Xov5vlsZXvvIzlrZjlnKggRUdGUiBUNzkwTSDnqoHlj5jpmLPmgKfnmoTlsYDpg6jmmZrmnJ/miJbovaznp7vmgKcgTlNDTEMgfAp8IOS8j+e+juabv+WwvCB8IDIwMjEuMy4yIHwgIHwg5pC65bimIEVHRlIgRGVsMTkg5ZKMIEw4NThSIOeqgeWPmOeahOaZmuacnyBOU0NMQyB8IOaXouW+gCBFR0ZSLVRLSSDmsrvnlpflkI7lh7rnjrDnlr7nl4Xov5vlsZXvvIzlrZjlnKggRUdGUiBUNzkwTSDnqoHlj5jpmLPmgKfnmoTlsYDpg6jmmZrmnJ/miJbovaznp7vmgKcgTlNDTEMgfAoK6LWE5paZ5p2l5rqQ77yaRkRB77yMTk1QQe+8jGluc2lnaHQg5pWw5o2u5bqT77yM5Lit5L+h6K+B5Yi456CU56m26YOo
所属报告:
迪哲医药-公司投资价值分析报告:转化医学平台领先引领中国源头创新走向世界的biotech-230518(47页).pdf
打包全文图表
相关数据
图表50艾玛昔替尼II/III期AS临床数据(应答率)
fCDmjIfmoIcgICAgICAgfCDlr7nnhafnu4TlupTnrZTnjocoJSkgfCDor5Xpqoznu4TlupTnrZTnjocoJSkgfAp8LS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS18CnwgQVNBUzIwICAgICB8IDI5LjAgICAgICAgICAgICAgfCA0OC43ICAgICAgICAgICAgIHwKfCBBU0FTNDAgICAgIHwgMTguMyAgICAgICAgICAgICB8IDMyLjEgICAgICAgICAgICAgfAp8IEFTQVM1LzYgICAgfCAxNS42ICAgICAgICAgICAgIHwgNDIuOCAgICAgICAgICAgICB8CgrotYTmlpnmnaXmupDvvJpaLkxpIGV0IGFsLiBBIG11bHRpY2VudGVyLCByYW5kb21pemVkLCBkb3VibGUgLSBibGluZCw=
收藏
行业数据
2025-09-28
原图定位
查看详情
图表51艾玛昔替尼II/III期AS数据(较基线变化)
fCDmjIfmoIcgICAgICAgICAgfCBQbGFjZWJvIHwgU0hSMDMwMiA0IG1nIHwKfC0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS18LS0tLS0tLS0tLS0tLS18CnwgQkFTREFJICAgICAgICB8IC0xLjQzICAgfCAtMi4yMSAgICAgICAgfAp8IEJBU0ZJICAgICAgICAgfCAtMC43OSAgIHwgLTEuMzMgICAgICAgIHwKfCBCQVNNSSAobGluZWFyKXwgLTAuMjkgICB8IC0wLjQwICAgICAgICB8CnwgQVNRb0wgICAgICAgICB8IC0yLjE4ICAgfCAtMy4xMyAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77yaWi5MaSBldCBhbC4gQSBtdWx0aWNlbnRlciwgcmFuZG9taXplZCwgZG91YmxlLWJsaW5kLA==
收藏
行业数据
2025-09-28
原图定位
查看详情
图34、罗昔替尼各适症国内与美国发进
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
收藏
行业数据
2025-08-19
原图定位
查看详情
吉卡昔替尼乳膏临床试验情况(截至2025.05.29)
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
收藏
行业数据
2025-08-01
原图定位
查看详情
舒沃替尼WU-KONG1PartB患者基线情况
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
收藏
行业数据
2025-06-23
原图定位
查看详情
戈利昔替尼与西达本胺的PFS曲线对比
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
收藏
行业数据
2025-06-23
原图定位
查看详情
戈利昔替尼与西达本胺不同亚型PTCL的ORR
fCDliIbnsbsgfCDmiIjliKnmmJTmm7/lsLwgWzFdIHwg6KW/6L6+5pys6IO6IFsyXSB8CnwtLS0tLS18LS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLXwKfCDooYDnrqHlhY3nlqvmr43nu4bog55U57uG6IOe5reL5be055ikIChBSVRMKSB8IDU2JSB8IDUwJSB8Cnwg6Z2e54m55oyH5Z6L5aSW5ZGoVOe7huiDnua3i+W3tOeYpCAoUFRDTC1OT1MpIHwgNDYlIHwgMjIlIHwKfCDoh6rnhLbmnYDkvKQvVOe7huiDnua3i+W3tOeYpCAoTksvVENMKSB8IDY3JSB8IDE5JSB8Cnwg5YW25LuW5Lqa5Z6LIHwgNDQlIHwgMTElIHw=
收藏
行业数据
2025-06-23
原图定位
查看详情
戈利昔替尼与已获批竞品疗效对比
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
收藏
行业数据
2025-06-23
原图定位
查看详情
戈利昔替尼与其它JAK抑制剂的选择性比较
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
收藏
行业数据
2025-06-23
原图定位
查看详情
戈利昔替尼与西达本胺临床疗效对比
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
收藏
行业数据
2025-06-23
原图定位
查看详情
戈利昔替尼与西达本胺停药率对比
5qC55o2u5oKo5o+Q5L6b55qE5L+h5oGv77yM5Lul5LiL5piv6KGo5qC85ZKM6LWE5paZ5p2l5rqQ77yaCgp8IOiNr+eJqSAgICAgICB8IOWBnOiNr+eOhyAgfAp8LS0tLS0tLS0tLS0tfC0tLS0tLS0tfAp8IOaIiOWIqeaYlOabv+WwvCB8IDcuMyUgICB8Cnwg6KW/6L6+5pys6IO6ICAgfCAxNi45JSAgfAoK6LWE5paZ5p2l5rqQ77ya5Zu95a625Yy755aX5L+d6Zqc5bGA77yM6byO5YW06K+B5Yi456CU56m25omA
收藏
行业数据
2025-06-23
原图定位
查看详情
戈利昔替尼与其它JAK抑制剂的PK比较
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
收藏
行业数据
2025-06-23
原图定位
查看详情
舒沃替尼分子式及结构设计亮点
fCDkuq7ngrkxIHwg5Lqu54K5MiB8IOS6rueCuTMgfAp8LS0tLS0tLXwtLS0tLS0tfC0tLS0tLS18Cnwg6Z225ZCR5YyF5ousRUdGUiBFeG9uMjBpbnPnqoHlj5jlnKjlhoXnmoTlpJrnp41FR0ZS56qB5Y+Y5Lqa5Z6LIHwg5L+d55WZ5a+5RUdGUuaVj+aEn+eqgeWPmOWPilQ3OTBN56qB5Y+Y55qE5oqX6IK/55ik5rS75oCnIHwg5pS55ZaE6I2v5Luj5Yqo5Yqb5a2m77yM5Lq65L2T5Y2K6KGw5pyf6ZW/6L6+57qmNTDlsI/ml7bvvIzmr4/ml6XkuIDmrKHlj6PmnI3lrp7njrDmjIHnu63nqLPlrprmipHliLYgfAoK6LWE5paZ5p2l5rqQ77ya5Yy76ISJ6YCa77yM5Zu95YWD6K+B5Yi456CU56m25omA
收藏
行业数据
2025-06-23
原图定位
查看详情
舒沃替尼WU-KONG1PartB全球亚组分析有效性数据
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
收藏
行业数据
2025-06-23
原图定位
查看详情
舒沃替尼WU-KONG6研究安全性
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
收藏
行业数据
2025-06-23
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
临床前研究显示舒沃替尼联合戈利昔替尼疗效优于单药。戈利昔替尼作为新一代、强效且高选择性 JAK1 抑制剂,可有效抑制 JAK/STAT 信号通路,有望通过和作用于 EGFR的舒沃替尼进行联用,解决 EGFR-TKIs 耐药患者的治疗问题。2023 年 1 月 9 日,CDE批准舒沃替尼与戈利昔替尼联合疗法治疗标准治疗失败的 EGFR 突变 NSCLC 患者的 II 期临床试验。临床前数据显示,在 EGFR 敏感突变和/或耐药突变的 NSCLC 移植瘤模型中,舒沃替尼联合戈利昔替尼均显示出抗肿瘤协同作用。
行业数据
原图定位
当前图表所属:
迪哲医药-公司投资价值分析报告:转化医学平台领先引领中国源头创新走向世界的biotech-230518(47页).pdf
表6资料来源),研究分析了三家医院EGFR20ins患者53例(占NSCLC患者的2.4%),
舒沃替尼与竞品药物的疗效和安全性比较
国内正在进行的ex20ins适应症临床试验及临床数据
现有三代EGFR抑制剂的获批适应症
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》